Sunday, September 22, 2024
HomeTagsAR882 Phase

AR882 Phase

Arthrosi Completes AR882 Phase 2B Study Enrollment

Arthrosi Therapeutics, Inc., a clinical-stage biotechnology company, announced the completion of enrollment for its global Phase 2b clinical study of AR882 for the treatment...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics